FWM
WINT

Frontier Wealth Management’s Windtree Therapeutics WINT Stock Holding History

Frontier Wealth Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed -$137K – 451
2021
Q2 		$137K Buy
+1
New +$97.3K 0.01% 414
2021
Q1 		– Sell
-1
Closed -$308K – 404
2020
Q4 		$308K Hold
1
– – 0.03% 290
2020
Q3 		$330K Hold
1
– – 0.03% 272
2020
Q2 		$420K Buy
+1
New +$317K 0.04% 232

Other funds holding WINT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Frontier Wealth Management's WINT Position: Q3 2021 in Review

Frontier Wealth Management sold out of Windtree Therapeutics (WINT) in Q3 2021, closing a stake of 1 share — an estimated $137K sold.

Frontier Wealth Management first reported a position in WINT in Q2 2020 and held it in 4 quarters. The position peaked at $420K in Q2 2020. 7 funds tracked by Wall St. Rank hold WINT as of Q3 2021.

  • Frontier Wealth Management reported no remaining Windtree Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Frontier Wealth Management sold 1 Windtree Therapeutics share in Q3 2021, an estimated $137K.
  • Frontier Wealth Management first reported a position in Windtree Therapeutics in Q2 2020 and held it in 4 quarters.
  • Frontier Wealth Management's Windtree Therapeutics position peaked at $420K in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q3 2021.

Based on Frontier Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.